Genprex is a clinical-stage biotechnology firm pioneering innovative gene therapies for cancer. Its lead candidate, Reqorsa, utilizes a non-viral delivery system to restore tumor-suppressor genes, targeting difficult-to-treat cancers like lung and pancreatic. This approach aims to halt tumor growth and enhance existing treatments, offering new hope for patients with limited options and advancing precision oncology.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends